Teresa Chi Ho

US Patent:

57831793, Jul 21, 1998

Filed:

Aug 9, 1991

Appl. No.:

7/743613

Inventors:

John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Deborah A. Eppstein - Palo Alto CA
Philip L. Felgner - San Diego CA
Barbara P. Barna - Berea OH
Sharad D. Deodhar - Shaker Heights OH

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 4505
A61K 3804
C07K 500

US Classification:

424 852

Abstract:

Compounds having immunomodulatory activity comprising the optionally modified dodecapeptide fragment A-(SEQ ID No: 1)-B corresponding to residues 174 to 185 of C-reactive protein (CRP), pharmaceutical compositions thereof, and methods of treating cancer with the compositions. Liposomal formulations containing the CRP-peptide fragment are particularly efficacious when administered in conjunction with interleukin-2.

US Patent:

57982252, Aug 25, 1998

Filed:

May 24, 1995

Appl. No.:

8/449500

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Brian H. Vickery - Mountain View CA
Chinh T. Bach - San Jose CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

C12N 1516
C12N 121
C12N 1563

US Classification:

435 694

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

55894526, Dec 31, 1996

Filed:

Jul 14, 1992

Appl. No.:

7/915247

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Brian H. Vickery - Mountain View CA
Chinh T. Bach - San Jose CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 3829
C07K 14635

US Classification:

514 12

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

56959559, Dec 9, 1997

Filed:

May 23, 1995

Appl. No.:

8/448070

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Brian H. Vickery - Mountain View CA
Chinh T. Bach - San Jose CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

C12P 2106

US Classification:

435 694

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, these residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa (Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

58408371, Nov 24, 1998

Filed:

May 24, 1995

Appl. No.:

8/449447

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 3829
C07K 1400

US Classification:

530324

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

58740864, Feb 23, 1999

Filed:

Jan 18, 1994

Appl. No.:

8/184328

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Brian H. Vickery - Mountain View CA
Chinh T. Bach - San Jose CA

Assignee:

Syntex (U.S.A,), Inc. - Palo Alto CA

International Classification:

A61K 3829

US Classification:

4241981

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

60516860, Apr 18, 2000

Filed:

May 23, 1995

Appl. No.:

8/447856

Inventors:

John L. Krstenansky - Palo Alto CA
John J. Nestor - Cupertino CA
Teresa H. Ho - Los Altos CA
Brian H. Vickery - Mountain View CA
Chinh T. Bach - San Jose CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 3800
C07K 1400
C07K 110

US Classification:

530333

Abstract:

Synthetic polypeptide analogs of parathyroid hormone PTH, parathyroid hormone related peptide PTHrp, and of the physiologically active truncated homologs and analogs of PTH and PTHrp, in which amino acid residues (22-31) form an amphipathic. alpha. -helix, said residues (22-31) selected from hydrophilic amino acids (Haa) and lipophilic amino acids (Laa) ordered in the sequence: Haa(Laa Laa Haa Haa). sub. 2 Laa and their pharmaceutically acceptable salts are useful for the prophylaxis and treatment of ostoporosis in mammals. Processes for the production of the polypeptides via solid phase and recombinant methods are provided.

US Patent:

20200394694, Dec 17, 2020

Filed:

Aug 27, 2020

Appl. No.:

17/004459

Inventors:

- San Francisco CA, US
Ankur Raina - Santa Clara CA, US
Teresa Ho - San Jose CA, US
Todd Winners - Ashburn VA, US

International Classification:

G06Q 30/06
G06F 16/29

Abstract:

Provided is an emergency management system including at least one processor in communication with an electronic payment processing network, the electronic payment processing network including a transaction processing system, a plurality of merchant systems associated with merchant locations, and a plurality of issuer systems. The at least one processor is programmed or configured to retrieve, from the electronic payment processing network, transaction data associated with a plurality of transactions and determine an operational status of at least one first entity associated with the plurality of transactions based on the difference between a first transaction count and a second transaction count, and in response to determining the operation status of the at least one first entity, automatically communicate a message to at least one second entity based on the operational status of the at least one first entity.